Rates of medication errors similar across countries The rates of medication errors in primary care are similar in health systems across the world, with most ranging between 6% and 8%, according to an international review…
Simvastatin has no therapeutic benefit in COPD, researchers concludeSimvastatin does not prevent exacerbations in people with moderate-to-severe chronic obstructive pulmonary disease (COPD)…
Long-acting interferon-beta cuts relapse rate in multiple sclerosisA new long-acting form of interferon-beta has shown significant efficacy versus placebo when used in patients with relapsing–remitting multiple sclerosis (MS), reveal results of a Phase III trial published online in The Lancet Neurology.…
There is more to access than you may thinkLuc Besançon, general secretary of the International Pharmaceutical Federation (FIP), urges readers to explore the many ways in which they can bring about healthy outcomes…
How treatment is labelled affects migraine pain scores, study findsGiving patients positive information about their treatment for acute migraine contributes to a successful outcome, whether the patient is given active drug or placebo, a US study has shown ( Science Translational Medicine ; 8 January 2013).…
SSRI use in late pregnancy linked to newborn pulmonary hypertensionInfants whose mothers took selective serotonin reuptake inhibitors (SSRIs) in late pregnancy may be at increased risk of persistent pulmonary hypertension of the newborn…
Nelson Mandela — healing a nation Sybil Seoka, immediate past president of the Pharmaceutical Society of South Africa, writes in memory of elder statesman Nelson Mandela, who died on 5 December 2013…
